Background: Isolated, nonsyndromic cleft lip with or without cleft palate is a common human congenital malformation with a complex and heterogeneous etiology. Genes coding for fibroblast growth factors and their receptors (FGF/FGFR genes) are excellent candidate genes.
Isolated, nonsyndromic cleft lip with or without cleft palate (iCL6P) represents one of the most common human birth defects (Mossey and Little, 2002) and has a complex and heterogeneous etiology that remains poorly understood (Jugessur and Murray, 2005) . There is a strong genetic component to the etiology of this common birth defect. A multifactorial threshold model of inheritance reflecting multiple distinct causal genes is often assumed (Grosen et al., 2010) . Genome-wide linkage screens in multiplex families have shown that multiple regions of the genome may harbor causal genes with a high degree of linkage heterogeneity (Marazita et al., 2004; Marazita et al., 2009) . Recently, genome-wide association studies (GWAS) have identified a region on chromosome 8q24 as strongly associated with risk for iCL6P; although, it is relatively devoid of genes, raising the possibility that noncoding genetic regions are also critical (Birnbaum et al., 2009; Grant et al., 2009; Beaty et al., 2010) . Several studies have also shown suggestive evidence for interaction between candidate genes and environmental risk factors, especially maternal smoking (Zeiger et al., 2005; Shi et al., 2007a) and nutrient intake (Shaw et al., 1998) in controlling risk for iCL6P; although, the evidence for gene-environment (G 3 E) interaction remains difficult to confirm. Therefore, genes and regulatory elements outside of coding regions, plus their possible interactions with each other (G 3 G interaction) and with environmental factors, should be considered when searching for potential causal genes for iCL6P.
Genes in the fibroblast growth factor (FGF) signaling pathway are excellent candidate genes for iCL6P (Nie et al., 2006; Riley et al., 2007a; Riley et al., 2007b; Riley et al., 2007c; Menezes et al., 2008) . Here we tested markers in 10 FGF and FGF receptor (FGFR) genes for their potential role in controlling risk to iCL6P using 297 case-parent trios from four populations.
MATERIALS AND METHODS

Sample Description
As part of an international study, we collected peripheral blood, environmental exposures, and other data on iCL6P case-parent trios recruited through treatment centers at Johns Hopkins and University of Maryland in Maryland (MD), Chang Gung Memorial Hospital in Taiwan (TW), KK Women's and Children's Hospital in Singapore (SP), and Yonsei Medical Center in South Korea (KR). History of maternal exposure to cigarette smoking, alcohol consumption, and vitamin supplementation was collected from a personal interview of mothers that covered the periconceptual period (3 months before conception through the first trimester). All probands underwent clinical genetic evaluation (including checking for other congenital anomalies or major developmental delays) and were classified as having an isolated, nonsyndromic iCL6P. Research protocols were reviewed and approved by institutional review boards at each participating institution.
Single-Nucleotide Polymorphism Selection, DNA, and Genotyping
Single-nucleotide polymorphisms (SNPs) were selected in 10 FGF/FGFR genes (including FGFBP1, FGF2, FGF10, FGF18, FGFR1, FGFR2, FGF19, FGF4, FGF3, and FGF9) with a goal of identifying one SNP per 5 kilobase pairs (kb) of physical distance. Because Hapmap data were not fully available at the time our SNPs were chosen, we could not identify all possible tagging SNPs. Variants with ''SNP scores'' .0.6 (an assessment of design quality of the Illumina assay based on a proprietary algorithm), high validation levels in the SNP database (dbSNP) (including validation on multiple platforms), and high heterozygosity levels (particularly in multiple populations) were given priority. The SNP markers were genotyped using Illumina's GoldenGate chemistry (Oliphant et al., 2002) at the Genetic Resources Core Facility (GRCF) at Johns Hopkins. Two duplicates and four controls from the Centre d'Etude du Polymorphisme Humain collection were included on each plate to evaluate genotyping consistency within and between plates.
Statistical Analysis
Genotyping rate, minor allele frequency (MAF), pairwise linkage disequilibrium (LD), and Hardy-Weinberg equilibrium (HWE) were evaluated within each population and in three Asian populations combined. The LD was measured as r 2 for all SNPs using Haploview (Barrett et al., 2005 ). The SNPs were tested when the following criteria were satisfied: MAF .1%, compatibility with HWE at p . .01 in each group, and overall genotyping rate .80%. None of the SNPs between different FGF/FGFR genes on the same chromosome were in LD (data not shown), so the 10 FGF/ FGFR genes were analyzed separately.
Statistical significance of transmission distortion from parents to the affected offspring was evaluated using the family-based association test (http://www.biostat.harvard. edu/,fbat/fbat.htm) for each individual SNP and for haplotypes of multiple SNPs (Laird and Lange, 2006) . Numbers of transmitted and nontransmitted alleles for both single SNPs and haplotypes were generated using PLINK v1.07 (http://pngu.mgh.harvard.edu/purcell/plink/, Purcell et al., 2007) . The 95% confidence interval for estimated odds ratios (ORs) of overtransmission were calculated by a binomial exact test in STATA (v. 10.0, StataCorp, 2007) .
Analysis of maternally mediated in utero effects was performed using the TRIad Multi-Marker (TRIMM) package under an assumption of mating symmetry in the population (Shi et al., 2007b) . Paired difference counts (D) of the number of target alleles carried by father and mother is a key component in constructing standardized normal (Z) statistics for the mean D across all markers, and the maximum Z 2 (max_Z 2 ) served as a test statistic. Empiric significance of maternal genotypic effects was evaluated by permuting these max_Z 2 values over random reassignments of ''father'' and ''mother.'' To optimize power, max_Z 2 and Hotelling T 2 tests were used to generate a combined p value (sum_logP) from these two tests. If the global max_Z 2 test gave a p , 0.1, the apparent risk allele or haplotype was used in the log-linear framework originally proposed by Weinberg et al. (1998) to estimate relative risks. Odds ratios and their significance associated with the mother's carrying one copy (S 1 ) of the risk allele/haplotype was assessed by a likelihood ratio test (LRT) under the log-additive model (where ORs associated with carrying two copies is simply S 1
2 ) as implemented in the Triad Multi-Marker relative risk estimation program (TRIMMEST) (http://www.niehs.nih. gov/research/atniehs/labs/bb/staff/weinberg; Shi et al., 2009 ). A general model was used to estimate the OR for FGF2, where four haplotypes were present, but a more restricted model assuming HWE was used for FGF10 where 11 haplotypes were observed (because the more general model would have required too many parameters). Family-based association tests for individual SNPs or twoto three-SNP sliding window haplotypes incorporating a G 3 E interaction term with maternal smoking and vitamin supplementation were performed in a combined 2 degrees of freedom (df) score test for main effects of genotype (G) and G 3 E interaction together, followed by a 1 df score test for G 3 E interaction alone using PBAT (v3.6; http://www.biostat. harvard.edu/,clange/default.htm).
We used Cordell's (2002) LRT for possible G 3 G interaction assessment among markers in these 10 FGF/ FGFR genes. Using a conditional logistic regression model, the observed two-locus genotype of the case was compared with the 15 possible ''pseudo-sib'' control genotypes, generating a 4 df test. To address the issue of multiple comparisons, we carried out permutation tests where case versus pseudo-sib control status was randomly shuffled 1000 times for each trio to generate new sets of data under the null hypothesis. An empirical p value for the most significant SNP was determined by comparing the observed test statistic with these 1000 replicates.
Although markers in these 10 FGF/FGFR genes were typed as part of a candidate gene study conducted before the international consortium described by Beaty et al. (2010) , 157 of these 297 (52.9%) case-parent trios went into that genome-wide study. In a confirmatory analysis of G 3 G interaction, we removed these overlapping trios from the international consortium data set and used all remaining case-parent trios (n 5 1434), which represents an independent replication sample of iCL6P case-parent trios.
RESULTS
A total of 297 trios were collected from four populations (MD, TW, SP, and KR), and Table 1 lists gender and race of all iCL6P probands. Among the 122 SNPs genotyped in these 10 FGF/FGFR genes, nine SNPs were dropped due to low MAF and another two SNPs were dropped due to low genotyping call rate. Genotype distributions for the remaining 111 SNPs were all compatible with HWE (data not shown).
When analyzing transmission distortion of individual SNPs among these 10 FGF/FGFR genes, two independent markers in FGF19 showed nominally significant evidence of linkage and association (p , .05) with iCL6P among Asian trios, and another SNP was significant only among MD trios (Table 2 ). Estimated ORs for carrying the apparent high-risk allele at each of these three FGF19 SNPs ranged from 1.37 to 1.87. Analysis of sliding window haplotypes using two to five SNPs together confirmed the significance of markers in FGF19 among Asian trios, and a three-SNP haplotype in FGFR1 (rs6987534, rs6474354, and rs10958700) gave p 5 .04 (corrected p 5 .30) among Asian trios.
In testing for possible maternal genotype effects, one four-SNP haplotype in FGF2 and another six-SNP haplotype in FGF10 showed significant empiric evidence of an increased risk of iCL6P in offspring that depended solely upon maternal genotype among Asian trios. The corresponding ORs for the child being affected were estimated as 1.72 (x 2 5 11.47, empiric p 5 .0007) and 1.61 (x 2 5 7.29, empiric p 5 .0069) if the mother carried one copy of the risk haplotype (Table 3) .
Although the rate of maternal alcohol consumption was too low to permit separate analysis, about 5% and 25% Asian mothers reported smoking and taking vitamin supplements, respectively, during the critical peri-conceptional period (Sull et al., 2009 ). Significant evidence of G 3 E interaction was seen among Asian populations for FGFR2 (Fig. 1) . For G 3 Smoking analysis, the most significant evidence was seen in a two-SNP haplotype (rs2981428 and rs3750817) that yielded a p 5 .0058 in a 1 df test (Fig. 1 ) that was not significant after strict Bonferroni correction. For G 3 Vitamin interaction, the strongest evidence in FGFR2 was seen both in 1 df test for a single SNP (rs2912771; p 5 .00027, corrected p 5 .042) and in the 2 df test for a three-SNP haplotype (involving rs4752566, rs2912760, and rs3135761; p 5 .00021, corrected p 5 .033). These p values for G 3 Vitamin interaction remained significant after strict Bonferroni correction for all 156 tests conducted on the 27 markers and their haplotypes in FGFR2. As seen in the lower panel of Figure 1 , several other SNPs and haplotypes also showed nominal significance in either the 1 df or the 2 df test for G 3 Vitamin interaction.
A total of 16 pairs of SNPs in different FGF genes attained nominal significance in tests of G 3 G interaction (Table 4 ). The most significant LRT was generated by rs2043278 in FGF18 and rs12870202 in FGF9 (p 5 .0001), Male  Female  Male  Female  Male  Female  Male  Female  Male  Female   European  41  29  0  0  1  1  0  0  4 2  3 0  African  3  3  0  0  0  0  0  0  3  3  Asian  0  0  95  51  23  10  22  18  140  79  Total  44  32  95  51  24  11  22  18  185  112 which remained significant (p 5 .019) after correcting for multiple comparisons via permutation tests. Only 1.9% of replicates (across the 338 separate tests for G 3 G interactions) generated under the null hypothesis exceeded this observed test statistic (Table 4 ; Fig. 2 ). To follow up on the intriguing evidence for G 3 G interaction between FGF9 and FGF18 seen here, an independent replication sample of 1434 case-parent trios was examined in a confirmatory test of G 3 G interaction using markers in these two genes. Only rs2043278 in FGF18 was included in the genome-wide marker panel, but 11 different SNPs in or near FGF9 gave a nominally significant evidence of G 3 G interaction with this one SNP (Table 5) . When all 38 SNPs in FGF18 were examined with the 140 SNPs mapping to FGF9, several additional pairs of SNPs in these two genes showed further evidence of possible G 3 G interaction (see Fig. 3 ). The most significant pairs involved SNPs located in the intergenic region 39 of the gene; some are as far as 500 kb away.
DISCUSSION
In our analysis of 111 markers in 10 FGF/FGFR genes using 297 case-parent trios collected from an international study, SNPs in seven of these genes gave some evidence of linkage and association with unobserved causal variants for iCL6P. Genes in the FGF/FGFR pathway are considered good candidates for iCL6P because they play important roles in craniofacial development (Kurose et al., 2004; Rice et al., 2004; Jugessur et al., 2009 ) and several of them (FGFR1, FGFR2, and FGF10) control Mendelian malformation syndromes that can include oral clefts as a The distance between rs3135761 and rs2912762 were drawn for clarity (true distance between these two SNPs is 199 base pairs). hallmark feature (Slaney et al., 1996; Dodé et al., 2003; Entesarian et al., 2005) . Genes can contribute to the etiology of nonsyndromic forms of oral clefts as well as Mendelian malformation syndromes, such as interferon regulatory factor 6 (Kondo et al., 2002; Zucchero et al., 2004) . Fine-mapping linkage scans in the 8p11-23 chromosomal region (Riley et al., 2007c) , association, and sequencing studies (Riley et al., 2007a; Riley et al., 2007b) offered further support for FGFR1 as a good candidate for iCL6P. Our analysis of markers in FGFR1 gene confirmed these previous reports. However, neither results from our or Riley's studies would retain statistical significance if strict Bonferroni correction for multiple testing were used. Although there is no previous evidence that FGF19 influences risk for iCL6P, our results combined with evidence from animal models (Kurose et al., 2004) suggest further investigation of this gene may be warranted.
Mutations in noncoding regions of FGF2 and FGF10 can result in impaired transcription (Riley et al., 2007b) . Our analysis showed intriguing evidence for maternal genotypic effects controlling the offspring's risk of iCL6P for markers in these two genes among Asians, though fetal effects identified in two previous studies for SNPs in FGF10 (Riley et al., 2007b; Menezes et al., 2008) were not confirmed here. Maternal genes control the in utero environment, so potential maternal genotype effects of markers in FGF2 and FGF10 genes seen among our Asian trios may be important (Boyles et al., 2009) .
Sequence analysis identified several rare mutations in coding regions of FGFR2, which may be causal (Riley et al., 2007a; Riley et al., 2007b) . In our study, SNPs in FGFR2 showed suggestive evidence of G 3 E interaction with maternal smoking and significant evidence of interaction with vitamin supplementation (even after Bonferroni correction). Evidence from association studies with markers in FGFR2 across studies has been inconsistent (Riley et al., 2007a; Menezes et al., 2008) , but our suggestion of G 3 E interaction deserves further investigation given the potential for public health intervention with modifiable environmental risk factors.
Potentially important mutations in noncoding regions of FGF9 were identified in a separate sequencing study (Riley et al., 2007a; Riley et al., 2007b) . Our analysis of 297 trios showed intriguing evidence for possible G 3 G interaction between FGF18 and FGF9 that may be important for iCL6P. Using independent trios from the International Cleft Consortium described by Beaty et al. (2010) , we confirmed the significance of G 3 G interaction between markers in FGF9 and FGF18 identified in these 297 trios, although the strongest evidence was seen for markers distal to the 39 end of FGF9 (well away from coding regions). The combination of statistical evidence from these 297 trios and from the 1434 independent trios from the GWAS makes it more likely these findings are biologically meaningful. Very few GWAS signals are actually found in coding sequences (Hindorff et al., 2009) , and the strongest association signal for iCL6P in Europeans lies in an apparent ''gene desert'' on chromosome 8q24 (Birnbaum et al., 2009; Grant et al., 2009; Beaty et al., 2010) . Similar regulators may underlie these associations, and one can imagine a shared enhancer sequence could explain the suggested interaction between these two FGF genes.
Our association results confirmed some previous findings from published linkage, association, and sequencing analysis for various FGF/FGFR genes and provided new clues about how these different genes may act through potential maternal genotypic effects and G 3 E and G 3 G interactions to control risk of iCL6P. Although some of the statistical evidence presented here did not retain significance after strict Bonferroni correction, mechanisms of G 3 G interaction in particular require further investigation.
